Jose Portilla-Arias Nanomedicine Research Center, Department of Neurosurgery Cedars-Sinai Medical Center Biography Publications Institution JoVE Articles Jose Portilla-Arias has not added a biography. If you are Jose Portilla-Arias and would like to personalize this page please email our Author Liaison for assistance. Publications Nanoparticles of Esterified Polymalic Acid for Controlled Anticancer Drug Release Macromolecular Bioscience. Jun, 2014 | Pubmed ID: 24902676 Toxicity and Efficacy Evaluation of Multiple Targeted Polymalic Acid Conjugates for Triple-negative Breast Cancer Treatment Journal of Drug Targeting. Dec, 2013 | Pubmed ID: 24032759 Polymalic Acid Nanobioconjugate for Simultaneous Immunostimulation and Inhibition of Tumor Growth in HER2/neu-positive Breast Cancer Journal of Controlled Release : Official Journal of the Controlled Release Society. Nov, 2013 | Pubmed ID: 23770212 Distinct Mechanisms of Membrane Permeation Induced by Two Polymalic Acid Copolymers Biomaterials. Jan, 2013 | Pubmed ID: 23063368 Cellular Delivery of Doxorubicin Via PH-Controlled Hydrazone Linkage Using Multifunctional Nano Vehicle Based on Poly(β-L-Malic Acid) International Journal of Molecular Sciences. 2012 | Pubmed ID: 23109877 Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer PloS One. 2012 | Pubmed ID: 22355336 Poly(methyl Malate) Nanoparticles: Formation, Degradation, and Encapsulation of Anticancer Drugs Macromolecular Bioscience. Oct, 2011 | Pubmed ID: 21793213 The Optimization of Polymalic Acid Peptide Copolymers for Endosomolytic Drug Delivery Biomaterials. Aug, 2011 | Pubmed ID: 21514661 Polymalic Acid-based Nanobiopolymer Provides Efficient Systemic Breast Cancer Treatment by Inhibiting Both HER2/neu Receptor Synthesis and Activity Cancer Research. Feb, 2011 | Pubmed ID: 21303974 Nanoplatforms for Constructing New Approaches to Cancer Treatment, Imaging, and Drug Delivery: What Should Be the Policy? NeuroImage. Jan, 2011 | Pubmed ID: 20149882 Nanoconjugate Platforms Development Based in Poly(β,L-Malic Acid) Methyl Esters for Tumor Drug Delivery Journal of Nanotechnology. 2010 | Pubmed ID: 23024655 Inhibition of Brain Tumor Growth by Intravenous Poly (β-L-malic Acid) Nanobioconjugate with PH-dependent Drug Release [corrected] Proceedings of the National Academy of Sciences of the United States of America. Oct, 2010 | Pubmed ID: 20921419 Temozolomide Delivery to Tumor Cells by a Multifunctional Nano Vehicle Based on Poly(β-L-malic Acid) Pharmaceutical Research. Nov, 2010 | Pubmed ID: 20387095 Nanoparticles Made of Microbial Poly(gamma-glutamate)s for Encapsulation and Delivery of Drugs and Proteins Journal of Biomaterials Science. Polymer Edition. 2009 | Pubmed ID: 19454169 Biodegradable Nanoparticles of Partially Methylated Fungal Poly(beta-L-malic Acid) As a Novel Protein Delivery Carrier Macromolecular Bioscience. Jun, 2008 | Pubmed ID: 18350538 Synthesis, Degradability, and Drug Releasing Properties of Methyl Esters of Fungal Poly(beta,L-malic Acid) Macromolecular Bioscience. Jun, 2008 | Pubmed ID: 18322913 Ionic Complexes of Biosynthetic Poly(malic Acid) and Poly(glutamic Acid) As Prospective Drug-delivery Systems Macromolecular Bioscience. Jul, 2007 | Pubmed ID: 17599336 Thermal Decomposition of Fungal Poly(beta,L-malic Acid) and Poly(beta,L-malate)s Biomacromolecules. Nov, 2006 | Pubmed ID: 17096562 Nanostructurated Complexes of Poly(beta,L-malate) and Cationic Surfactants: Synthesis, Characterization and Structural Aspects Biomacromolecules. Jan, 2006 | Pubmed ID: 16398511 Biopolímeros Nano basados en ácido polimálico de Focalización de múltiples Marcadores tumorales: una oportunidad para la medicina personalizada? Julia Y. Ljubimova1, Hui Ding1, Jose Portilla-Arias1, Rameshwar Patil1, Pallavi R. Gangalum1, Alexandra Chesnokova1, Satoshi Inoue1, Arthur Rekechenetskiy1, Tala Nassoura1, Keith L. Black1, Eggehard Holler1 1Nanomedicine Research Center, Department of Neurosurgery, Cedars-Sinai Medical Center JoVE 50668 Chemistry
Biopolímeros Nano basados en ácido polimálico de Focalización de múltiples Marcadores tumorales: una oportunidad para la medicina personalizada? Julia Y. Ljubimova1, Hui Ding1, Jose Portilla-Arias1, Rameshwar Patil1, Pallavi R. Gangalum1, Alexandra Chesnokova1, Satoshi Inoue1, Arthur Rekechenetskiy1, Tala Nassoura1, Keith L. Black1, Eggehard Holler1 1Nanomedicine Research Center, Department of Neurosurgery, Cedars-Sinai Medical Center JoVE 50668 Chemistry